HL Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$885K Sell
13,608
-2,364
-15% -$157K 0.01% 399
2018
Q4
$999K Sell
15,972
-20,367
-56% -$1.42M 0.02% 362
2018
Q3
$2.81M Sell
36,339
-1,151
-3% -$86.9K 0.04% 249
2018
Q2
$2.66M Sell
37,490
-1,122
-3% -$79.2K 0.05% 245
2018
Q1
$2.91M Sell
38,612
-18,835
-33% -$1.5M 0.05% 213
2017
Q4
$4.12M Sell
57,447
-2,416
-4% -$183K 0.08% 153
2017
Q3
$4.85M Sell
59,863
-458
-0.8% -$35K 0.09% 126
2017
Q2
$4.27M Sell
60,321
-536
-0.9% -$35.7K 0.09% 144
2017
Q1
$4.13M Sell
60,857
-4,516
-7% -$318K 0.08% 138
2016
Q4
$4.68M Sell
65,373
-14,458
-18% -$1.07M 0.1% 123
2016
Q3
$6.32M Buy
79,831
+3,813
+5% +$310K 0.15% 97
2016
Q2
$6.34M Buy
76,018
+9,292
+14% +$825K 0.15% 91
2016
Q1
$6.13M Buy
66,726
+7,144
+12% +$644K 0.15% 86
2015
Q4
$6.03M Sell
59,582
-13,638
-19% -$1.42M 0.15% 84
2015
Q3
$7.19M Buy
73,220
+25,732
+54% +$2.86M 0.2% 72
2015
Q2
$5.56M Buy
47,488
+15,472
+48% +$1.69M 0.15% 94
2015
Q1
$3.14M Buy
32,016
+3,781
+13% +$384K 0.08% 153
2014
Q4
$2.66M Buy
28,235
+2,793
+11% +$289K 0.07% 166
2014
Q3
$2.71M Sell
25,442
-3,934
-13% -$385K 0.08% 161
2014
Q2
$2.44M Buy
29,376
+8,348
+40% +$650K 0.07% 176
2014
Q1
$1.49M Buy
21,028
+960
+5% +$75.3K 0.05% 204
2013
Q4
$1.51M Sell
20,068
-300
-1% -$20.9K 0.05% 207
2013
Q3
$1.28M Buy
20,368
+2,149
+12% +$128K 0.04% 207
2013
Q2
$934K Buy
+18,219
New +$950K 0.03% 232

Other funds holding GILD

HL Financial Services's GILD Position: Q1 2019 in Review

HL Financial Services reduced its Gilead Sciences (GILD) stake by 15% in Q1 2019, selling an estimated $157K and leaving 13,608 shares worth $885K. The position accounts for 0.01% of the portfolio, ranked #399.

HL Financial Services first reported a position in GILD in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.19M in Q3 2015. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • HL Financial Services held 13,608 shares of Gilead Sciences worth $885K as of Q1 2019.
  • HL Financial Services sold 2,364 Gilead Sciences shares in Q1 2019, an estimated $157K.
  • Gilead Sciences made up 0.01% of HL Financial Services's portfolio in Q1 2019, its #399 holding.
  • HL Financial Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 24 quarters since.
  • HL Financial Services's Gilead Sciences position peaked at $7.19M in Q3 2015.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.